Clinical trial
TELI TAD - Telithromycin in Tonsillitis in Adolescents and Adults
NCT00315549 · Sanofi, Industry · Terminated
Key facts
| NCT number | NCT00315549 |
|---|---|
| Title | TELI TAD - Telithromycin in Tonsillitis in Adolescents and Adults |
| Official title | Multinational, Randomized, Double Blind, Comparative Study to Evaluate the Efficacy and Safety of 5 Days Telithromycin 800 mg od Versus 10 Days Penicillin V 500 mg Tid in Adolescent and Adult Subjects Equal to or Over 13 Years With Streptococcus Pyogenes Tonsillitis/Pharyngitis |
| Lead sponsor | Sanofi, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Tonsillitis, Pharyngitis |
| Intervention type | Drug |
| Interventions | Telithromycin, Penicillin |
| Enrollment | 233 |
| Start date | Feb 1, 2006 |
| Primary completion | Sep 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Apr 18, 2006 |
| Last update posted | Apr 3, 2009 |
| Countries | Argentina, Chile, Costa Rica, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: